Psilocybin dosing and adult neurogenesis
Psilocybin is a psychedelic compound that alters states of consciousness to allow free imagination and insightful creativity. Its ability to induce complex behavioral and psychological changes has led to its resurgence in psychedelic-enhanced psychotherapy. Despite positive clinical efficacy from ahandful of trials, an optimal (or even variable) treatment paradigm has yet to be established. Here, in partnership with Zylorion, a psychedelics-based biopharmaceutical company, we will test different doses and treatment paradigms, to be followed by testing in mice major depression models andeventual clinical validation in individuals suffering from mental health conditions.